EdgeTestMarket TodayOptions TodayIPO
Start free

ASTERDMAster DM Quality Care Limited

Rs 647▲ +0.35%
Market closedEquity EOD 26 Oct
Compare
52-week rangeThe lowest and highest prices the stock traded at over the last year, from each day's intraday low and high. The marker is today's close: 0% means it sits at the year's low, 100% at the high. It describes where the price is, not where it is going.34.4% up the range
Rs 519Rs 891
ASTERDM price
Daily candles, adjusted for splits and bonus issues so a corporate action does not show as a crash. Pick a window from one month to the full history, add indicators, or open it full screen.
EOD 26 Oct
IndicatorsVolume

Loading ASTERDM price...

At a glance
Each figure is shown against the company's sector (the track: the dot is this company, the tick is the sector middle) and, where we hold the yearly filings, against its own recent years (the small trend line).
Market capWhat the whole company is worth on the stock market today: share price times the number of shares. It measures size, not quality.
Rs 33,523 cr
Larger than 74% of 19 peers
sector middle Rs 9,487 cr
P/EPrice to earnings: how many rupees investors pay for each rupee of profit the company made over the last twelve months. Compare it with similar companies rather than reading it alone.
104.9x
Higher than 82% of 17 peers
sector middle 52.9x
Price to bookPrice to book: the share price divided by the shareholders' money per share in the latest balance sheet. Around 1 means the market values the company close to its book value.
7.3x
Higher than 67% of 18 peers
sector middle 5.6x
ROEReturn on equity: the year's profit as a percentage of the shareholders' money in the business. It shows how much the company earns on what its owners have put in.
7.5%
Lower than 76% of 17 peers
sector middle 12.1%
FY23 9.8%FY26 8.8%
ROCEReturn on capital employed: operating profit as a percentage of all the long-term money in the business, owners' and lenders'. It shows how well the company uses its capital, whatever the mix of debt.
10.2%
Lower than 67% of 18 peers
sector middle 12.4%
FY23 8.4%FY26 10.2%
Debt to equityBorrowings divided by shareholders' money. 0 means no borrowings; 1 means it owes as much as its owners have put in. Not shown for banks and lenders, whose borrowing is their business.
0.15
Lower than 61% of 18 peers
sector middle 0.26
FY23 0.47FY26 0.15
Dividend yieldDividends paid over the last year as a percentage of the company's market value: roughly what Rs 100 of shares paid out in cash.
0.2%
Higher than 56% of 18 peers
sector middle 0.1%
Sales growthHow much the latest quarter's sales grew against the same quarter a year earlier.
+21.6%
Higher than 56% of 16 peers
sector middle +19.4%
FY23 16.4%FY26 12.2%

Peers are the listed companies in the exchange's own industry group: Hospital. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

What the numbers say
Short lines written by fixed rules from the company's own filings and shareholding. A line appears only when the figures cross the rule (for example sales growing three years running), and each names the numbers behind it. Nothing here is a view on whether to own the share.

Latest quarterIn the quarter to June 2026 (results filed 5 Aug 2026), sales rose 21.6% from a year earlier to Rs 1,311 cr and profit fell 68.7% to Rs 29.3 cr.

Going well
  • Operating margin rose from 13.1% in FY23 to 19.4% in FY26.

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

How the share moved on results
For each quarterly result we hold: the change from the share's close on the last trading day before the filing to its close on the first trading day after it. Results can land during market hours or after the close, and this window covers both. It shows what happened, not what will happen next time.

Over the last 20 results, the share rose on 13 and fell on 7, and moved by 3% or more on 10.

Q1 FY23Q1 FY24Q1 FY25Q1 FY26Q1 FY27

Q1 FY27: results filed 5 Aug 2026. The share went from its close on 4 Aug 2026 to its close on 6 Aug 2026 +1.17%.

Where every Rs 100 of sales goes
From the company's own yearly results. Each year is scaled to that year's sales, so you compare shares, not size: how much went on running costs, depreciation, interest and tax, and how much was left as profit.
5 financial years
Sales, last 12 months
Rs 4,876 Cr
Profit, last 12 months
Rs 363 Cr
Earnings per share
Rs 6.2
Profit growth (qtr, YoY)
-68.70%

Of every Rs 100 of sales in FY26, Rs 81 went on running costs, Rs 5.7 on depreciation, Rs 2.6 on interest and Rs 3.1 on tax; Rs 9.2 was left as profit.

FY22
86
FY23
87
FY24
87
FY25
82
131
FY26
81
9.2
Sales (Rs 100)Other incomeRunning costsDepreciationInterestTaxProfitOther itemsOther gains

Thin bar: money in (sales plus other income). Thick bar: where it went. Each year is scaled to its own sales, so the bars compare shares, not size.

How fast it has grown
Compound growth per year in sales, profit and earnings per share between financial years, from the company's own results. A span appears only if our filings cover both ends of it.
Sales
3 yrs
-27.0%/yr
Latest qtr
+21.6%
Profit
3 yrs
-3.5%/yr
Latest qtr
-68.7%

Per year, compounded, between financial years FY26 and the year named; only spans our filings cover. The faint bar is the latest quarter against the same quarter a year earlier. Earnings per share is not shown: filed figures are not adjusted for bonus issues and splits, so its growth would mislead.

Health check, year by year
Margins, returns, debt and interest cover for each financial year. Each row is coloured against this company's own usual level, so you see what is improving and what is slipping.
MeasureFY22FY23FY24FY25FY26
Sales growthSales against the previous financial year.-16.4%-6.0%-63.1%12.2%
Operating marginProfit from operations, before depreciation, interest and tax, per Rs 100 of sales.14.5%13.1%13.3%18.5%19.4%
Net marginProfit after everything, per Rs 100 of sales.5.9%4.0%1.9%131%9.2%
ROEProfit as a percentage of shareholders' money (from the March balance sheet).-9.8%4.2%148%8.8%
ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'.-8.4%2.2%10.7%10.2%
Debt to equityBorrowings divided by shareholders' money. Lower is safer.-0.47x0.13x0.18x0.15x
Interest coverHow many times operating profit covers the interest bill. Higher is safer.3.5x2.6x2.2x5.0x5.9x

Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).

What it owns, and how that is paid for
Straight from the March balance sheet in the company's annual filing. Both bars are the whole balance sheet: what the company owns, and where the money for it came from.
as at 2026-03-31

At FY26 it owned Rs 8,112 Cr of assets. Its owners funded 60% of that and borrowings 9%.

What it owns
37%
12%
16%
26%
Plant, property and projects3,031 Cr
Goodwill and intangibles283 Cr
Investments973 Cr
Inventory91 Cr
Owed by customers307 Cr
Cash and bank1,325 Cr
Everything else2,101 Cr
How that is paid for
60%
26%
Shareholders4,834 Cr
Borrowings701 Cr
Owed to suppliers482 Cr
Other liabilities2,096 Cr
Cash and equivalents
Rs 228 Cr
Net debt
Rs 472 Cr
Current ratio
1.99x
short-term assets per rupee due soon
Book value / share
Rs 88
Return on assets
4.5%
EV / EBITDA
34.2x

From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.

Where the cash went
Profit is an accounting figure; cash flow is what actually moved. Cash from running the business, plus or minus what was spent on or received from investments, plus or minus what came from or went to lenders and shareholders, equals the change in cash.

In FY26 the business itself brought in Rs 656 Cr, spent Rs 469 Cr on plant and equipment, and cash rose by Rs 63 Cr over the year.

From running the business
+656 Cr
Spent on or received from investing
-288 Cr
From or to lenders and shareholders
-304 Cr
Net change in cash
+63 Cr
Cash from operations for every Rs 100 of profit
Rs 386
FY23
Rs 75
FY24
Rs 8
FY25
Rs 154
FY26

Rs 100 or more means every rupee of reported profit arrived as cash.

Full financial year to 2026-03-31, from the company's cash flow statement.

Against its sector
Where this stock sits within its own sector on each measure. The marker is its position in the peer group and the notch is the sector median. A position is a fact about the cohort, not a view on the stock.
Hospital · 28
P/E104.86vs 52.93 median
Cheapest: JLHL 8.84Priciest: LOTUSEYE 1419.5
Net margin7.44%vs 10.23% median
Lowest: LOTUSEYE 0.26%Highest: MAXHEALTH 16.73%
Revenue growth21.6%vs 19.39% median
Lowest: INDRAMEDCO 11.26%Highest: NH 78.05%
Compared against
AATMAJABHAGARWALEYEAPOLLOHOSPARTEMISMEDDRAGARWQFORTISGKSLGPTHEALTHHCGINDRAMEDCOJLHLKIMSKMCSHILLOTUSEYEMAITREYAMANIPALHOSMAXHEALTHMEDANTAMOMSBELIEFNEPHROCARENHPARKHOSPSRAINBOWSANGANISHALBYUNIHEALTHYATHARTH

Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.

Peers side by side
Every company in the same NSE industry group that we hold figures for, largest first. Tap any heading to sort by it. The same figures as the At a glance tiles, worked out the same way for every company.
Hospital · 20 shown
Company
APOLLOHOSP
Apollo Hospitals Enterprise Limited
1.13 L cr54.0x11.9x21.8%19.5%0.578.2%+20.6%0.26%
MAXHEALTH
Max Healthcare Institute Limited
81,266 cr56.0x7.6x13.6%12.7%0.3216.7%+16.7%0.18%
MANIPALHOS
Manipal Health Enterprises Limited
73,581 cr--------
FORTIS
Fortis Healthcare Limited
55,467 cr52.9x5.6x10.5%12.0%0.2811.3%+17.5%0.14%
NH
Narayana Hrudayalaya Ltd.
33,971 cr41.4x7.5x18.0%11.4%1.079.0%+78.0%0.27%
ASTERDM
Aster DM Quality Care Limited
33,523 cr104.9x7.3x7.5%10.2%0.157.4%+21.6%0.16%
MEDANTA
Global Health Limited
32,575 cr58.6x8.2x13.9%15.1%0.3011.8%+26.5%0.04%
KIMS
Krishna Institute of Medical Sciences Limited
28,123 cr131.3x12.5x7.6%8.2%1.274.6%+35.3%0.74%
AGARWALEYE
Dr. Agarwal's Health Care Limited
15,065 cr102.2x7.4x8.7%9.7%0.078.4%+26.0%0.01%
RAINBOW
Rainbow Childrens Medicare Limited
11,802 cr41.3x7.2x17.4%16.8%0.0015.9%+33.2%0.26%
PARKHOSPS
Park Medi World Limited
9,487 cr-4.7x-18.1%0.11--0.00%
YATHARTH
Yatharth Hospital & Trauma Care Services Limited
8,924 cr49.3x4.9x9.7%11.0%0.1413.1%+52.3%0.00%
HCG
Healthcare Global Enterprises Limited
8,508 cr367.6x6.4x2.4%6.9%0.651.3%+13.4%0.00%
ARTEMISMED
Artemis Medicare Services Limited
4,547 cr40.0x4.9x12.1%13.7%0.2410.2%+12.7%0.13%
INDRAMEDCO
Indraprastha Medical Corporation Limited
2,750 cr20.8x3.7x25.4%30.7%0.0012.3%+11.3%1.49%
JLHL
Jupiter Life Line Hospitals Limited
1,658 cr8.8x1.1x12.1%13.8%0.3312.0%+18.2%0.40%
GKSL
Gujarat Kidney And Super Speciality Limited
1,400 cr70.8x5.5x6.6%8.6%0.0616.6%-0.00%
SHALBY
Shalby Limited
1,240 cr32.9x1.2x3.7%7.9%0.543.2%+11.7%0.00%
GPTHEALTH
GPT Healthcare Limited
1,066 cr22.6x4.0x17.6%16.4%0.069.6%+17.8%1.92%
LOTUSEYE
Lotus Eye Hospital and Institute Limited
236 cr1419.5x3.9x0.2%1.1%0.190.3%+26.2%0.00%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

The business
Sales and net profit from the company's own filings, by financial year or by quarter. Hover any bar for that period's complete figures including operating margin and the change against the comparable earlier period. The single TTM figure above is the sum of the last four quarters.
5 years · 20 quarters
Full financial years - the long arc of the business.
Sales growth
-27.0%
a year, 3 years
Profit growth
-3.5%
a year, 3 years
Operating margin
19.4%
latest year
Sales by financial yearRs 4,643 Cr
Net profit by financial yearRs 427 Cr
FY225 full years · hover a yearFY26

Operating margin has gone from 14.5% to 19.4% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.

Dividends paid
Cash paid per share, from the exchange's corporate-action record, restated to today's share count across bonuses and splits. Dates shown are ex-dates: you must own the shares before that date to receive the payment.
0.46% yield
Rs 460 / year
Paid 3 of 3 yrs
on Rs 1 lakh at today's price · 0.46% yield · Rs 3/share
What each year paid, on Rs 1 lakh
18,547
618
464
24
25
26*
* 2026 so far - more may still be declared this year

2026 has paid Rs 3.00 per share, about Rs 464 on Rs 1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.

Large institutional deals
Bulk and block deals reported by the exchange, where a single large trade is disclosed along with the counterparty's name. Only deals above the exchange's disclosure threshold appear here.
last 8
DatePartySideQtyPriceValue
2026-09-02UNION (MAURITIUS) HOLDINGS LIMITEDBUY46,09,800760Rs 350.34 Cr
2026-09-02UNION (MAURITIUS) HOLDINGS LIMITEDBUY46,09,800760Rs 350.34 Cr
2026-09-02CENTELLA MAURITIUS HOLDINGS LIMITEDSELL46,09,800760Rs 350.34 Cr
2026-09-02CENTELLA MAURITIUS HOLDINGS LIMITEDSELL46,09,800760Rs 350.34 Cr
2026-08-19CENTELLA MAURITIUS HOLDINGS LIMITEDSELL5,81,00,000766.17Rs 4,451.45 Cr
2026-08-19HDFC MUTUAL FUNDBUY97,89,107766.1Rs 749.94 Cr
2026-08-19CITIGROUP GLOBAL MARKETS SINGAPORE PTE LIMITEDBUY52,88,000766.1Rs 405.11 Cr
2026-08-19HDFC MUTUAL FUNDBUY52,20,857766.1Rs 399.97 Cr
Technical snapshot
Momentum, trend and delivery-based conviction from the actual price and volume history.
EOD 26 Oct
RSI (14) - momentum
31.1Neutral
0 oversold3070overbought 100
Delivery % - genuine buying vs churn
74.6%Near average
today 74.6%20d avg 59.3%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50-DMA
-12.37%
vs 200-DMA
-9.18%
1-month
-14.87%
3-month
-17.65%
1-year
-7.49%
Realized vol (30d)
28.8%
Insider trading disclosures
Promoter, director and other insider trades in the company's own shares, as disclosed to the exchange under SEBI's insider-trading regulations - usually within a few days of the transaction.
last 18 months

Insider trading data unavailable.

Recent announcements
The company's own filings to the exchange - results, board meetings, investor calls - with a link to the source document.
last 6 months

Announcements unavailable.

Want to test a strategy on ASTERDM?

Backtest an equity strategy on real market data, free - no card needed.

Start free

Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.